GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Other Operating Expense

Abliva AB (OSTO:ABLI) Other Operating Expense : kr99.99 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Other Operating Expense?

Abliva AB's Other Operating Expense for the three months ended in Mar. 2024 was kr18.17 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr99.99 Mil.

Abliva AB's quarterly Other Operating Expense declined from Sep. 2023 (kr32.94 Mil) to Dec. 2023 (kr27.59 Mil) and declined from Dec. 2023 (kr27.59 Mil) to Mar. 2024 (kr18.17 Mil).

Abliva AB's annual Other Operating Expense declined from Dec. 2021 (kr123.30 Mil) to Dec. 2022 (kr26.05 Mil) but then increased from Dec. 2022 (kr26.05 Mil) to Dec. 2023 (kr44.39 Mil).


Abliva AB Other Operating Expense Historical Data

The historical data trend for Abliva AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Other Operating Expense Chart

Abliva AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.88 60.39 123.30 26.05 44.39

Abliva AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 21.29 32.94 27.59 18.17

Abliva AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr99.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abliva AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Abliva AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Abliva AB (OSTO:ABLI) Business Description

Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines